Deletion of IL-4Rα Signaling on B Cells Limits Hyperresponsiveness Depending on Antigen Load
Overview
Authors
Affiliations
Background: B cells play an important role in allergies through secretion of IgE. IL-4 receptor α (IL-4Rα) is key in allergic asthma and regulates type 2 cytokine production, IgE secretion, and airway hyperresponsiveness. IL-4 activation of B cells is essential for class switching and contributes to the induction of B effector 2 (Be2) cells. The role of Be2 cells and signaling via IL-4Rα in B cells is not clearly defined.
Objective: We sought to find out whether IL-4Rα-responsive B cells or Be2 function was essential in experimental allergic asthma.
Methods: Mice lacking IL-4Rα on B cells (mb1IL-4Rα) or littermate controls (IL-4Rα) and mice lacking IL-4 or IL-4/IL-13 on B cells were sensitized and challenged with high-dose house dust mite (>10 μg) or with low-dose house dust mite (<3 μg). We also adoptively transferred naive IL-4Rα or IL-4Rα B cells into μMT mice a day before sensitization or a day before challenge. We analyzed lung inflammation, cellular infiltrate, and airway hyperresponsiveness.
Results: We found that IL-4Rα signaling on B cells was important for optimal T2 allergic immune responses mainly when the load of antigen is limited. IL-4Rα signaling on B cells was essential for germinal centers and in the effector phase of allergic responses. Be2 cells were essential in airway hyperresponsiveness, but not in other parameters.
Conclusions: IL-4Rα signaling on B cells is deleterious in allergic asthma because it is required for optimal T2 responses, Be2 function, germinal center formation, and T follicular helper cells, especially when the load of the antigen is limiting.
Adoptive Transfer of B Cells In Vivo for Assessment of Their Immune Function.
Hadebe S Methods Mol Biol. 2025; 2909:3-17.
PMID: 40029511 DOI: 10.1007/978-1-0716-4442-3_1.
Piecing Together the Role of IL-4 Receptor Alpha in Allergic Asthma One Cell at a Time.
Curtiss M, Rothman P Am J Respir Cell Mol Biol. 2024; 71(6):630-631.
PMID: 39292201 PMC: 11622632. DOI: 10.1165/rcmb.2024-0309ED.
Choudhary I, Lamichhane R, Singamsetty D, Vo T, Brombacher F, Patial S Am J Respir Cell Mol Biol. 2024; 71(6):702-717.
PMID: 39254378 PMC: 11622633. DOI: 10.1165/rcmb.2024-0208OC.
celakovska J, cermakova E, Boudkova P, Andrys C, Krejsek J Dermatol Ther (Heidelb). 2023; 13(5):1193-1210.
PMID: 37071375 PMC: 10149537. DOI: 10.1007/s13555-023-00922-2.
Daramola A, Akinrinmade O, Fajemisin E, Naran K, Mthembu N, Hadebe S Immunother Adv. 2023; 3(1):ltac023.
PMID: 36789295 PMC: 9912260. DOI: 10.1093/immadv/ltac023.